Please login to the form below
KOLs
This page shows the latest KOLs news and features for those working in and with pharma, biotech and healthcare.
Current and future trends for developing digital medical communications
Products that may fit into this area include KOL mapping tools (such as our proprietary expert identification and engagement tool called Nucleus POLAR), AI-driven personalised content websites and social media
Latest news
-
The digital shift in pharma marketing
KOL webinar preference further increased to 69%, asserting its global dominance as the most preferred channel to reach HCPs. ... Globally, KOL webinars and social media continue to dominate as the most preferred channels in both called-on and white-space
-
Biogen defends aducanumab filing plan amid scepticism
GlobalData analyst Alessio Brunello said today that key opinion leaders (KOLs) polled by the company “expressed mixed opinion about the potential approval from FDA as its standard of approval is substantial
-
Indegene Pharma Marketer 2020 Report predicts significant shift in channel spends
While brand portals, KOL webinars and social media are frequently used channels, third party websites and online journals in the US and tele-detailing in Europe/Asia received the highest rating
-
GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing
Company seeking to revive lacklustre marketing performance. GlaxoSmithKline is to reverse its ban on paying healthcare professionals and key opinion leaders (KOLs), admitting that the policy has hit awareness of its ... GSK says it will now return to
-
Taming the Monster
physicians and KOLs.
More from news
Approximately 2 fully matching, plus 109 partially matching documents found.
Latest Intelligence
-
Facing up to virtual reality
That scientific content – which can be visualised and presented by KOLs in innovative, digitally enhanced ways – provides the platform for a virtual engagement event, for example, one week later. ... Here, those same KOLs can present bite-sized
-
AI and genomics: a revolution in drug discovery and development
Using our approach we quickly identified and validated with multiple KOLs 33 additional genes that were strongly associated with ALS.”.
-
Case study: 4 Sites – Navigating the course ahead
A UK Steering Committee of Gastroenterology KOLs looked to develop an agenda to provide meaningful, practical education on T2T. ... board. Delegates want more from a stand- alone, including follow-up education via self-led remote learning, both on-
-
Breaking from tradition - social media at medical congresses
4. Provide a platform for others.Could you tick both the value-added and partnership boxes by helping your Key Opinion Leaders (KOLs) to develop their profile using your corporate social ... Increasingly, as well as planning offline symposia and speaking
-
The social dilemma: is it time for pharma to join the party?
One potential area is Key Opinion Leader (KOL) development. Pharma builds much of its engagement model around KOLs. ... Tapas Mukherjee. But is the industry’s emphasis on KOLs dictating – and perhaps even restricting – modern HCP engagement?
More from intelligence
Approximately 7 fully matching, plus 37 partially matching documents found.
Latest appointments
-
Ashfield appoints new UK head of patient solutions
She has also worked with many key opinion leaders (KOLs) and facilitated advisory boards to aid the delivery of new models of patient care pathways, and was the winner of the
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Unpacking rare diseases in the first edition of Delta magazine
Why you need to build relationships with KOLs and patients much earlier than you think.
-
Unpacking rare diseases in the first edition of Delta magazine
Why you need to build relationships with KOLs and patients much earlier than you think.
-
Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
Sandra has extensive experience working in physician, patient, and brand strategy; product marketing; digital; and KOL engagement. ... We discuss a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal
-
Madmicrobe Studios
EXHIBITIONS &EVENTS. As your KOLs deliver their keynotes to a full house, larger-than-life stage graphics can support and enhance messaging and aid audience engagement.
-
Demonstrating the value of HCP self-serve portals
For example, rather than monitoring the number of ‘plays’ for a KOL video or page views for a patient case study, you might monitor the number/percentage of target HCPs that
More from PMHub
Approximately 5 fully matching, plus 43 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- FDA approves new self-injection administration for Xolair
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
